SEC Form 4 · accession 0001209191-17-025766
ANTARES PHARMA, INC. · ATRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert F Apple
Officer — President & CEO · Director
Period of report
Apr 4, 2017
Accepted (ET)
Apr 5, 2017 · 5:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001016169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 4, 2017 | M | 37,000 | $1.65 | A | 927,002 | D | |
| Common Stock | Apr 4, 2017 | S | 37,000 | $3.0019 | D | 890,002 | D | |
| Common Stock | Apr 5, 2017 | M | 3,000 | $1.65 | A | 893,002 | D | |
| Common Stock | Apr 5, 2017 | S | 3,000 | $3.00 | D | 890,002 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $1.65 | Apr 4, 2017 | M | 37,000 | D | — | May 10, 2017 | Common Stock | 37,000 | 3,000 | D |
| Stock Option (right to buy)F2 | $1.65 | Apr 5, 2017 | M | 3,000 | D | — | May 10, 2017 | Common Stock | 3,000 | 0 | D |
Explanation of responses
- F1The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. The exercised stock option reported on this Form 4 was due to expire on May 10, 2017.
- F2The options vested and became exercisable in equal quarterly installments over three years following the grant date of May 10, 2007.